Biomarkers could reveal increased comorbid risk

Danish researchers measured the levels of C-reactive protein, fibrinogen and leukocyte in the blood of more than 8600 adult COPD patients, then assessed hospital admissions for comorbidities in the group over a median five years.

They found COPD patients with elevated levels of all three biomarkers were more than twice as likely to suffer from ischaemic heart disease or have a myocardial infarction and 2.6 times more likely to have heart failure, than patients with biomarkers at lower levels.

Elevated biomarkers were also linked to a four-fold